Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Brothers Life Sciences Lp
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   28,278,373    

Indirect Shares

   99,473,529      
Direct Value   $941,991,056    

Indirect Value

   $2,801,738,789      
Total Shares   127,751,902      
Total Value   $3,743,729,845      


Synageva BioPharma Corp $0 XOMA Corporation $327,634,719 Genomic Health Inc $576,459,614 Acadia Pharmaceuticals Inc $3,143,891 Incyte Corp $7,037,243 Alexion Pharmaceuticals Inc $24,083,248 Beigene Ltd $3,047,349 Kiniksa Pharmaceuticals, Ltd. $584,993 Synageva BioPharma Corp $0 XOMA Corporation $327,634,719 Genomic Health Inc $576,459,614 Acadia Pharmaceuticals Inc $3,143,891 Incyte Corp $7,037,243 Alexion Pharmaceuticals Inc $24,083,248 Beigene Ltd $3,047,349 Kiniksa Pharmaceuticals, Ltd. $584,993
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    13   
    1    

     Stock price went up :
    11   
    0    
     Stock price went down :
    2   
    1    
   
     Gain/Loss Ratio :
   5.5   
   -1.0   
     Percentage Gain/Loss :
   19.7%
 -23.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA Director 2012-07-13 5,077,676 0    Premium*  
            XOMA Corporation XOMA Director 2012-07-19 13,606,093 0    Premium*  
            Genomic Health Inc GHDX Director 2012-07-26 9,086,690 0    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2023-06-01 205,752 2023-06-01 39,330,977    Premium*  
            Seagen Inc SGEN Former 10% Owner, Dire... 2023-12-14 0 2023-12-14 0    Premium*  
            Incyte Corp INCY Director, 10% Owner 2017-09-08 119,681 2017-09-08 822,826    Premium*  
            Aceragen, Inc ACGN Director 0 2014-03-10 1,613,076    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2017-06-15 131,963 2017-06-15 1,074,556    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2023-11-14 20,838 2023-11-14 9,878,124    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 2021-11-18 0 2021-11-18 7,625,425    Premium*  
            Tscan Therapeutics, Inc. TCRX Director, 10% Owner 2022-05-10 0 2022-05-11 2,528,583    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 2022-06-13 0 2022-06-13 29,190,248    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director 2023-06-06 29,680 2023-06-06 2,719,343    Premium*  
            Igm Biosciences, Inc. IGMS Director 2023-06-30 0 2023-09-29 2,896,968    Premium*  
            Madrigal Pharmaceuticals Inc MDGL Director 2023-11-14 0 2023-12-14 1,793,403    Premium*  
* Premium Members only  

Records found :    114         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SGEN Seagen Inc Director   –       •       •   2016-02-22 4 B $30.21 $7,354,639 I/I 243,411 35,475,868 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-18 4 B $29.94 $7,530,349 I/I 251,534 34,800,251 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-29 4 B $30.34 $7,650,310 I/I 251,722 35,985,436 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-09-09 4 B $50.33 $12,917,842 I/I 256,220 39,260,675 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-16 4 B $29.19 $8,049,663 I/I 270,163 33,847,095 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-03-09 4 B $34.62 $9,556,609 I/I 275,717 24,998,817 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-04 4 B $31.68 $9,322,814 I/I 288,058 36,627,462 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-10 4 B $32.30 $9,386,567 I/I 290,231 37,278,782 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-09-14 4 B $44.68 $14,849,199 I/I 320,438 31,538,611 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-11-08 4 B $59.46 $19,403,299 I/I 326,300 40,885,092 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-05-21 4 B $43.27 $15,723,084 I/I 362,459 27,005,386 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-05-20 4 B $40.95 $15,929,271 I/I 374,298 26,652,609 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-11-03 4 B $56.55 $21,586,884 I/I 379,336 40,361,400 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-02 4 B $32.24 $13,068,812 I/I 400,000 36,367,808 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-11-06 4 B $41.31 $17,529,497 I/I 417,924 32,582,794 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-03-03 4 B $34.76 $14,814,701 I/I 425,220 24,699,479 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-05-06 4 B $35.85 $16,530,995 I/I 453,995 25,993,083 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-11-02 4 B $55.84 $26,200,958 I/I 466,619 40,019,506 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-19 4 B $29.20 $14,790,559 I/I 506,526 35,257,100 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-11-09 4 B $43.00 $22,200,588 I/I 507,300 33,090,094 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-05-05 4 B $33.99 $18,419,925 I/I 530,952 25,539,088 2.25 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2023-05-24 4 B $25.27 $14,096,825 I/I 553,263 39,317,673 2.25 %
SGEN Seagen Inc Director   –       •       •   2016-03-16 4 B $31.50 $18,084,600 I/I 569,203 38,671,506 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-09-15 4 B $46.31 $30,237,807 I/I 626,259 32,164,870 2.25 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2017-06-15 4 B $116.54 $77,012,491 I/I 656,387 980,146 2.1 -
  114  Records found
  1   2   3   4  5      
  Page 4 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us